DGX Quest Diagnostics Incorporated

$180.22

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/22/2025

About Quest Diagnostics Incorporated

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Website: https://www.questdiagnostics.com

Sector
LIFE SCIENCES
Industry
SERVICES-MEDICAL LABORATORIES
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1022079
Address
500 PLAZA DRIVE, SECAUCUS, NJ, US
Valuation
Market Cap
$18.18B
P/E Ratio
21.33
PEG Ratio
1.48
Price to Book
2.68
Performance
EPS
$7.68
Dividend Yield
1.95%
Profit Margin
8.82%
ROE
13.80%
Technicals
50D MA
$168.63
200D MA
$156.92
52W High
$178.00
52W Low
$125.83
Fundamentals
Shares Outstanding
111M
Target Price
$179.27
Beta
0.78

DGX EPS Estimates vs Actual

Estimated
Actual

DGX News & Sentiment

Aug 21, 2025 • Zacks Commentary NEUTRAL
Why Is Quest Diagnostics ( DGX ) Up 8.2% Since Last Earnings Report?
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aug 21, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Should Quest Diagnostics Stock Be in Your Portfolio Right Now?
DGX drives growth with advanced diagnostics, acquisitions and cost savings, but rising debt and macro risks weigh on its outlook.
Aug 20, 2025 • Zacks Commentary NEUTRAL
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
HOLX's Genius digital cytology system and global rollout position its Cytology unit for long-term growth despite near-term headwinds.
Aug 18, 2025 • Zacks Commentary BULLISH
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Aug 18, 2025 • Benzinga BULLISH
MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD To Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused On $24.46 Billion Corporate Wellness Market - MedWellAI ( OTC:MWAI )
CLEARWATER, Fla., Aug. 18, 2025 /PRNewswire/ -- MedWell Ai, Inc, ( "Company" ) MWAI is pleased to confirm the collaboration and execution of Software Development Agreement with BrighterMD, to develop and launch Company's latest initiative: TeleMD.Ai - Nationwide B2B and B2C Healthcare and ...
Aug 14, 2025 • Zacks Commentary BULLISH
Here's Why Quest Diagnostics ( DGX ) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Sentiment Snapshot

Average Sentiment Score:

0.346
50 articles with scored sentiment

Overall Sentiment:

Bullish

DGX Reported Earnings

Apr 21, 2025
Mar 31, 2025 (Pre market)
0.06 Surprise
  • Reported EPS: $2.21
  • Estimate: $2.15
  • Whisper:
  • Surprise %: 2.8%
Jan 30, 2025
Dec 31, 2024 (Pre market)
0.05 Surprise
  • Reported EPS: $2.23
  • Estimate: $2.18
  • Whisper:
  • Surprise %: 2.1%
Oct 22, 2024
Sep 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $2.30
  • Estimate: $2.26
  • Whisper:
  • Surprise %: 1.8%
Jul 23, 2024
Jun 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $2.35
  • Estimate: $2.34
  • Whisper:
  • Surprise %: 0.4%
Apr 23, 2024
Mar 31, 2024 (Pre market)
0.18 Surprise
  • Reported EPS: $2.04
  • Estimate: $1.86
  • Whisper:
  • Surprise %: 9.7%
Feb 01, 2024
Dec 31, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $2.15
  • Estimate: $2.11
  • Whisper:
  • Surprise %: 1.9%
Oct 24, 2023
Sep 30, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $2.22
  • Estimate: $2.19
  • Whisper:
  • Surprise %: 1.4%
Jul 26, 2023
Jun 30, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $2.30
  • Estimate: $2.27
  • Whisper:
  • Surprise %: 1.3%
Apr 27, 2023
Mar 31, 2023 (Pre market)
0.07 Surprise
  • Reported EPS: $2.04
  • Estimate: $1.97
  • Whisper:
  • Surprise %: 3.5%

Financials